The S-100 is a group of low molecular weight (10-12 kD) calcium-bindin
g proteins highly conserved among vertebrates. It is present in differ
ent tissues as dimers of homologous or different subunits (alpha,beta)
In the nervous system, the S-100 exists as a mixture composed of beta
beta and alpha beta dimers with the monomer beta represented more oft
en. Its intracellular localisation is mainly restricted to the glial c
ytoplasmic compartment with a small fraction bound to membranes. In th
is compartment the S-100 acts as a potent inhibitor of phosphorylation
on several substrates including the synaptosomal C-Kinase and Tau, a
microtubule-associated protein. The S-100 in particular conditions, af
ter binding with specific membrane sites (K-d = 0.2 mu M; B-max = 4.5
nM), is able to modify the activity of adenylate cyclase, probably via
G-proteins. In addition, the Ca2+ homeostasis is also modulated by S-
100 via an increase of specific membrane conductance and/or Ca2+ relea
se from intracellular stores. ''In vitro'' and ''in vivo'' experiments
showed that lower (nM) concentrations of extracellular S-100 beta act
on glial and neuronal cells as a growth-differentiating factor. On th
e other hand, higher concentrations of the protein induce apoptosis of
some cells such as the sympathetic-like PC12 line. Finally, data obta
ined from physiological (development, ageing) or pathological (dementi
a associated with Down's syndrome, Alzheimer's disease) conditions sho
wed that a relationship could be established between the S-100 levels
and some aspects of the statii.